8300 Fair Value & Analysis
Financial Services · Market cap 448M SAR
Fair value as of: Jul 31, 2026
From 15 valuation models · updated today
Share price −16.4% over the past month.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (12 months)
12‑month range 11.20 SAR – 16.45 SAR · fair‑value band 9.04 SAR – 15.07 SAR · the 11.20 SAR price screens below the 12.05 SAR fair value. As of Jul 31, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
8300 (8300) currently trades at 11.20 SAR, while our model-based Fair Value estimate is 12.05 SAR, implying the stock looks roughly 7.6% fairly valued today. We read business quality at 39/100 (below-average quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, 8300 generated revenue of 2.1B SAR at a net margin of 1.0%. Revenue grew 40.6% year over year. It earns a return on equity of 3.3%. The balance sheet holds a net cash position of 99.1M SAR. Fundamentals as of Jul 31, 2026
Our scenario range runs from 9.04 SAR (bear case) to 15.07 SAR (bull case); at 11.20 SAR, the current price sits within that range. The share trades about 32% below its 52-week high, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -16% fair-value upside, at 8%, 8300 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
8300 reported revenue of 1.9B SAR in FY2025 versus 559M SAR in FY2021, a compound +35.8%/yr. Reported net income was 37.1M SAR in FY2025.
Is 8300 fairly valued? → Check now
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Berkshire Hathaway Inc BRYN | €423.40 | €346.77 | -18% |
| Allianz SE ALV | €381.50 | €309.45 | -19% |
| Zurich Insurance Group ZURN | CHF 557.00 | CHF 526.58 | -5% |
| AXA SA AXAN | 795.49 MXN | 1,003 MXN | +26% |
| Assicurazioni Generali S.p.A ARZGY | $24.04 | $19.38 | -19% |
| Sun Life Financial Inc SLF | C$104.47 | C$87.84 | -16% |
| American International Group AIGB34 | R$394.65 | R$91.86 | -77% |
| The Hartford Insurance Group H1IG34 | R$727.00 | R$1,310 | +80% |
| BB Seguridade Participações S.A BBSE3 | R$38.63 | R$58.14 | +51% |
| Tryg A/S TRYG | kr 150.80 | kr 109.55 | -27% |
Compare 8300 with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is 8300 overvalued or undervalued?
What is the fair value of 8300?
What is the quality score of 8300?
What is the revenue of 8300?
What is the net profit margin of 8300?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track 8300 and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.